Anti Nuclear Antibody (ANA) -Titres, in Visit Clinic

An Anti-Nuclear Antibody (ANA) test is a blood test that detects autoantibodies targeting cell nucleus components. It's used to screen for autoimmune connective-tissue diseases such as systemic lupus erythematosus, scleroderma and Sjögren's syndrome. Positive results require clinical correlation and further specific antibody tests because low-titer positives can occur in healthy people; patterns and titers guide diagnosis and management.

ANA titres measure the concentration of antinuclear antibodies in the blood, indicating the degree of immune activity against cell nuclei. Higher titres increase suspicion for autoimmune connective-tissue diseases (for example, lupus, scleroderma, Sjögren’s), while low titres can occur in healthy people or infections. Titre level and staining pattern guide further specific antibody testing and must be interpreted alongside clinical findings.

An ANA test requires a simple blood draw. A technician collects a blood sample from a vein, which is sent to a laboratory for analysis using methods like indirect immunofluorescence or ELISA. Results report presence, titer and pattern of antinuclear antibodies, helping assess autoimmune conditions. No special preparation is usually needed; results typically return in a few days and may prompt follow-up testing.

ANA testing helps diagnose autoimmune disorders by detecting antinuclear antibodies. It's used in evaluating systemic lupus erythematosus, Sjögren’s syndrome, systemic sclerosis (scleroderma), mixed connective tissue disease, polymyositis/dermatomyositis, rheumatoid arthritis in some cases, autoimmune hepatitis and drug‑induced lupus. A positive ANA supports further specific antibody testing and clinical assessment rather than a definitive diagnosis alone.

ANA is reported as dilution titres (e.g., 1:40, 1:80, 1:160). Many labs use 1:40 or 1:80 as the lower cutoff for positivity, but low titres are common in healthy people. Titres ≥1:160 (or higher) are more likely to reflect autoimmune disease. Interpretation depends on staining pattern and clinical context; a positive ANA alone is not diagnostic.

Yes. Several medications can cause a positive ANA or drug‑induced lupus, including hydralazine, procainamide, isoniazid, minocycline, some anticonvulsants and biologics (e.g., anti‑TNF agents). Drug‑related ANA often involves anti‑histone antibodies and usually improves after stopping the drug. Clinicians interpret ANA results alongside symptoms and medication history; repeat testing after discontinuation may clarify if it was drug‑related.